New Jersey attracts life science workers from across the nation with its access to culture, entertainment, economic and transportation centers like Philadelphia and New York City. With 124 biotechnology companies, New Jersey is now the fourth-largest biotechnology center in the nation. To assist in the development of this important industry cluster, the Biotechnology Council of New Jersey (BCNJ) was formed exclusively with representatives of biopharmaceutical, biomedical, bioagricultural and bioremedial enterprises.
Recognizing the importance of public information, the BCNJ engaged Deloitte, working together with Economic Development Research Group, to survey BCNJ members, document their economic activity in New Jersey, and identify the full range of impacts that the industry has on supporting jobs and income in the state. Results are available in the final report.
Full Report: The Biotech Council of NJ: 2003 Economic Impact Survey (pdf)